Impact on Patients With Neuromuscular and Musculoskeletal Conditions Associated With Benign Chronic Pain Using Atlas Profilapxis
CompletedNot applicableNCT07745088
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
AtlasPROfilax®is a method performed in 2 authorized centers in Colombia focused on patients with chronic non-malignant pain. The study seeks to see the effectiveness of the method in different pathologies through a randomized double-blind study.
Study details
- Official title
- Impact on Patients With Neuromuscular and Musculoskeletal Conditions Associated With Benign Chronic Pain Using Atlas Profilapxis
- Conditions
- Pain
- Pain Intervention
- Interventions
- Other: Placebo
- Procedure: Atlasprofilax Therapy
- Sponsor
- Fundacion Nacional Somos
- Collaborators
- Cooperative University of Colombia
- Start date
- 2022-01-01
- Primary completion
- 2024-06-01
- Sex
- All
- Age range
- from 18 Years to 85 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Colombia
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults over the age of 18 * patient who consult the authorized Atlas care center * patients with chronic non-malignant pain. Exclusion Criteria: * Inability to perform physical therapies. * patient with pain neuropatict indiferent
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07745088